A new strategy to understand how HIV infects women: Identification of a window of vulnerability during the menstrual cycle

AIDS

Volumn 22, Issue 15, 2008, Pages 1909-1917

  Wira, Charles R ^a   Fahey, John V ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MICROBICIDE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE; TOLL LIKE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; FEMALE GENITAL SYSTEM; GENITAL SYSTEM; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPOTHESIS; IMMUNE SYSTEM; IMMUNOREGULATION; INNATE IMMUNITY; MENOPAUSE; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UTERINE ENDOCERVIX; UTERINE TUBE; UTERUS; VAGINA; VAGINA SECRETION; VAGINAL LAVAGE; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS TRANSMISSION;

CONTRACEPTIVES, ORAL, HORMONAL; DISEASE SUSCEPTIBILITY; FEMALE; GENITALIA, FEMALE; GONADAL STEROID HORMONES; HIV INFECTIONS; HIV-1; HUMANS; MENSTRUAL CYCLE;

EID: 53549135475     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283060ea4     Document Type: Review

References (65)

1. UNAIDS 2007. AIDS epidemic update JUNPoHAUaWHOW, Geneva, Switzerland: UNAIDS; 2007.
2. Padian N, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007; 370:251-261.
3. Cohen J. Promising prevention interventions perform poorly in trials. Science 2007; 317:440.
4. Cohen J. AIDS research. Promising AIDS vaccine's failure leaves field reeling. Science 2007; 318:28-29.
5. Editorial team. Phase III anti-HIVmicrobicide trial in Africa and India stopped as preliminary results show gel may increase risk of infection. Euro Surveill 2007; 12:1-2. E070208.070206 [Epub ahead of print].
6. Honey K. Microbicide trial screeches to a halt. J Clin Invest 2007; 117:1116.
7. Piot P. San Francisco Chronicle (May 9, 2007) 2007.
8. CDC. HIV/AIDS Surveillance Report 2003 AUDoHaHS. CDC; 2003.
9. UNAIDS. AIDS epidemic update [global summary]. UNAIDS; 2004.
10. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMI 1992; 304:809-813.
11. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Laeyen-decker XLO, Kiwanuka N, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
12. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AID5 1996; 10 (Suppl A):S75-S82.
13. Quinn TC. Epidemiologic trends in HIV infection. Curr Opin Infect Dis 1992; 5:189-200.
14. Colfax GN, Buchbinder SP, Cornelisse PG, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 2002; 16:1529-1535.
15. Wira CR, Fahey JV, White HD, Yeaman GR, Given AL, Howell AL. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser S, Aplin J, Guidice L, Tabibzadeh S, editors. The endometrium, New York: Taylor and Francis; 2002. pp. 371-404.
16. Wira CR, Crane-Godreau MA, Grant-Tschudy KS. Role of sex hormones and cytokines in regulating the mucosal immune system in the female reproductive tract. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W, editors. Mucosal immunology, New York: Academic Press; 2005. pp. 1661-1678.
17. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in the female genital tract: cellular responses and interactions. In: Mayer L, editor. Immunological reviews. Blackwell Munskgaard; 2005. pp. 306-335.
18. Yeaman GR, Howell AL, Weldon S, Damien DJ, Collins JE, O'Connell DM, et al. HIV receptor and coreceptor expression on human uterine epithelial cells during the menstrual cycle. Immunology 2003; 109:137-146.
19. Yeaman GR, Asin S, Weldon S, Demian DJ, Collins JE, Wira CR, et al. Chemokine receptor expression in the human cervix: implications for infection by the human immunodeficiency virus-type I (HIV-1). Immunology 2004; 113:524-533.
20. Haase A. erils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005; 5:783-792.
21. Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 1996; 11:627-632.
22. Kunz GD, Beil H, Deiniger A, Einspanier G, Mall G, Leyendecke G. The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol 1997; 424:267-277.
23. Parsons AK, Cone RA, Moench TR. Uterine uptake of vaginal fluids: implications for microbicides. Presented at Microbicides 2002, Antwerp, Belgium; 2002. p. 136 (abstract B-175).
24. Settlage D, Motoshima M, Tredway D. Sperm transport from the external cervical os to the fallopian tubes in women: a time and quantitation study. Fertil Steril 1973; 24:655-661.
25. Bagasra O, Freund M, Weidmann J, Harley G. Interaction of human immunodeficiency virus with human sperm in vitro. J Acquir Immune Defic Syndr 1988; 1:431-435.
26. Brogi A, Presentini R, Solazzo D, Piomboni P, Costantino-Ceccarini E. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. AIDS Res Hum Retroviruses 1996; 12:483-489.
27. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, Guyre PM, Wira CR. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of Fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997; 38: 350-359.
28. Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leuk Biol 1997; 61:427-435.
29. Wallace PK, Yeaman GR, Johnson K, CollinsJE, Guyre PM, Wira CR. MHC class II expression and antigen presentation by endometrium cells. J Steroid Biochem Mol Biol 2001; 76:203-211.
30. Wira CR, Rossoll RM, Young RC. Polarized uterine epithelial cells preferentially present antigen at the basolateral surface: role of stromal cells in regulating class II mediated epithelial cell antigen presentation. J Immunol 2005; 175:1795-1804.
31. McCluskie M, Cartier J, Patrick A, Sajic D, Weeratna R, Rosenthal K, Davis H. Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848). Antiviral Res 2006; 69:77-85.
32. Smith JM, Wira CR, Fanger MW, Shen L. Human fallopian tube neutrophils: a distinct phenotype from blood neutrophils. AJRI 2006; 56:218-229.
33. Sentman CL, Meadows SK, Wira CR, Eriksson M. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004; 173:6760-6766.
34. Wira CR, Fahey J, Wallace P, Yeaman GR. Effect of the menstrual cycle on immune parameters in the human female reproductive tract. J Acquir Immune Defic Syndr 2005; 38:S34-S36.
35. Wira C, Fahey J, Schaefer T, Paoli P, Sentman C, Shen L. Innate and adaptive immunity in the human female reproductive tract: influence of the menstrual cycle and menopause on the mucosal immune system in the uterus. In: Glasser S, Aplin J, Giudice L, Tabibzadeh S, editors. The endometrium: molecular, cellular and clinical perspectives, 2nd ed. London: Informa Healthcare; 2007. pp. 491-521. Chapter 33.
36. Yeaman GR, Fazleabas AT, Wira CR. Endometrial lymphoid aggregates. Mucosal Immunol Update 2004; 12:6-8.
37. White HD, Crassi KM, Givan AL, Stern JE, Gonzalez JL, Memoli VA, et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997; 158:3017-3027.
38. White HD, Musey L, Andrews MM, Yeaman GR, DeMars LR, Manganiello PD, et al. HlV-specific and CD3-redirected cytotoxic T lymphocyte activity in human female reproductive tract tissues: lack of correlation between mucosa and peripheral blood. J Infect Diseases 2001; 183:977-983.
39. Sato K, Kawasaki H, Nagayama H, Enomoto M, Morimoto C, Tadokoro K, et al. TCF-beta 1 reciprocally controls Chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol 2000; 164:2285-2295.
40. Casslén B, Sandberg T, Gustavsson B, Willén R, Nilbert M. Transforming growth factor betal in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1. Biol Reprod 1998; 58:1343-1350.
41. Sullivan DA, Richardson GS, MacLaughlin DT, Wira CR. Variations in the levels of secretory component in human uterine fluid during the menstrual cycle. J Steroid Biochem 1984; 20:509-513.
42. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly (l:C). J Immunol 2005; 174:992-1002.
43. Fahey JV, Wright JA, Shen L, Smith JA, Ghosh M, Rossoll RM, Wira CR. Estradiol modulation of innate immune function by polarized human uterine epithelial cells in culture. Nature Mucosal Immunol (in press).
44. Fahey JV, Wira CR. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis 2002; 185:1606-1613.
45. Eriksson M, Meadows S, Wira C, Sentman C. Endogenous transforming growth factor-beta inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am J Reprod Immunol 2006; 56:321-328.
46. Pioli P, Jensen A, Weaver L, Amiel E, Shen Z, Shen L, et al. Estradiol attenuates lipopolysaccharide-induced CXC chemo-kine ligand 8 production by human peripheral blood monocytes. J Immunol 2007; 179:6284-6290.
47. Pioli PA, Weaver LK, Schaefer TM, Wright JA, Wira CR, Guyre PM. LPS-induced IL-1β production by human uterine macrophages upregulates uterine epithelial cell expression of human β-defensin 2. J Immunol 2006; 176:6647-6655.
48. Shen L, Smith JM, Shen Z, Eriksson M, Sentman C, Wira CR. Inhibition of human neutrophil degranulation by transforming growth factor-beta1. Clin Exp Immunol 2007; 149:155-161.
49. Wira CR, Rossoll RM, Ochiel DO, Haddad SN, Schaefer TM. Effect of estradiol and PAMPs on class II mediated antigen presentation and immunomodulatory molecule expression in the mouse female reproductive tract [abstract]. Am J Reprod Immunol 2006; 55:412.
50. Piguet V, Steinman R. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 2007; 28:503-510.
51. White HD, Crassi K, Wira CR. Cytolytic functional activities of NK cells and cytotoxic T lymphocytes (CTL) are coordinately regulated in the human female reproductive tract. In: Husband AJ, Beagley KW, Clancey RL, Collins AM, Cripps AW, Emery DL, editors. Mucosal solutions: advances in mucosal immunology, Sydney, Australia: The University of Sydney; 1997. pp. 385-391.
52. Schumacher GFB. Soluble proteins in cervical mucus. In: Blandau RJ, Moghissi K, editors. The biology of the cervix, Chicago: The University of Chicago Press; 1973. pp. 201-233.
53. Kutteh KW, Moldoveanu Z, Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998; 14:S51-S55.
54. Nardelli-Haefliger DJ, Wirthner D, Schiller J, Lowy D, Hildesheim A, Ponci F, Grandi P. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Nat Cancer Inst 2003; 95:1128-1137.
55. Keller M, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, et al. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 2007; 21:467-476.
56. QuayleAJ, Martin Porter E, Nussbaum AA, Wang YM, Brabec C, Yip K-P, Mok SC. Gene expression, immunolocalization and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998; 152:1247-1258.
57. Venkataraman N, Cole A, Svoboda P, Pohl J, Cole AL. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol 2005; 175:7560-7567.
58. Cole A, Cole A. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. AJRI 2008; 59:27-34.
59. Sambhara S, Lehrer RI. The inate immune system: a repository for future drugs? Expert Rev Anti Infect Ther 2007; 5:1-5.
60. Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 2008; 214:456-464.
61. Cohen M. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med 2004; 12:104-107.
62. Baeten J, Ludo Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. HIV/AIDS 2007; 45:360-369.
63. Bulterysa M, Smith D, Chao A, Jaffee H. Hormonal contraception and incident HIV-1 infection: new insight and continuing challenges. AIDS 2007; 21:97-99.
64. Prakash M, Kapembwa M, Gotch F, Patterson S. Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women. J Reprod Immunol 2002; 54:117-131.
65. Gillgrass AE, Ashkar AA, Rosenthal KL, Kaushic C. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol 2003; 77:9845-9851.